BioSpace News Archive

Voluntis (Paris:VTX) (Euronext Paris, Ticker: VTX - ISIN: FR0004183960), a leader in digital therapeutics, announced today a collaboration with Novartis to evaluate the use of Voluntis’ digital therapeutic platform for Breast Cancer patients with the goal to empower patients with tools to more effectively manage symptoms and, thereby, improve patient experience and outcomes.

In response to today’s announcement of Trump administration proposals to allow importation of certain prescription drugs, the American Pharmacists Association (APhA) today expressed its overwhelming concerns for patient safety.

A group of more than 650 nephrologists have joined with Fresenius Medical Care North America (FMCNA), the nation’s leading provider of kidney care products and services, to raise $20 million in initial funding and announce the formation of InterWell Health, a population health management company focused on supporting the renal patient population across the full continuum of care.